Interface Biologics Inc.
logo BDC

Interface Biologics Inc.

Interface Biologics is a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.

Our partnership

Interface is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Dion Madsen, Founding partner at Amplitude Venture Capital.

Investment year:  2005
Industry sector:  Devices
Region:  Ontario
Website
Follow Interface Biologics Inc.
v17.9.0.10395